The past 2 decades have witnessed extraordinary advances in our understanding of the genetic factors influencing inflammatory bowel disease (IBD), providing a foundation for the approaching era of genomic medicine. These involve elucidation of the genetic architecture of IBD (how it compares across populations, the role of rare variants, and prospects of polygenic risk scores), in-depth cellular and molecular characterization (fine-mapping causal variants, cellular contributions to pathology, mo...
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via PubMed.
| Category | 🧬 Medicine & Biology |
| Published | Jan 06, 2025 |
| Journal | Inflammatory bowel diseases |
| Authors | Gibson Greg, Rioux John D, Cho Judy H, Haritunians Talin, Thoutam Akshaya |
| DOI | 10.1093/ibd/izae269 |
| Source | PubMed |